RAC Hears a Plea for Resuming Trials, Despite Cancer Risk

Vaccination News Home Page                                            subscribe Vaccination NewsLetter

http://www.sciencemag.org/content/vol299/issue5609/news-summaries.shtml

GENE THERAPY:
RAC Hears a Plea for Resuming Trials, Despite Cancer Risk

Jocelyn Kaiser

After learning more about the leukemias in two patients in a French gene-therapy trial, a U.S. review panel this week suggested that although it makes sense to keep this trial on hold, others might be allowed to resume. The panel also learned that a third patient in the French trial has a gene insertion like the one in the two who developed leukemia--although this child does not have leukemia.

Full Text

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.